Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Rockwell Medical (RMTI) Interest Expenses (2019 - 2026)

Rockwell Medical filings provide 7 years of Interest Expenses readings, the most recent being $286000.0 for Q4 2025.

  • On a quarterly basis, Interest Expenses fell 1.04% to $286000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $1.1 million, a 10.37% decrease, with the full-year FY2025 number at $1.1 million, down 10.37% from a year prior.
  • Interest Expenses hit $286000.0 in Q4 2025 for Rockwell Medical, roughly flat from $285000.0 in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $1.1 million in Q4 2023 to a low of $232000.0 in Q2 2024.
  • Median Interest Expenses over the past 5 years was $421000.0 (2023), compared with a mean of $449000.0.
  • Biggest five-year swings in Interest Expenses: soared 469.61% in 2021 and later crashed 73.92% in 2024.
  • Rockwell Medical's Interest Expenses stood at $588000.0 in 2021, then fell by 25.34% to $439000.0 in 2022, then skyrocketed by 152.39% to $1.1 million in 2023, then crashed by 73.92% to $289000.0 in 2024, then fell by 1.04% to $286000.0 in 2025.
  • The last three reported values for Interest Expenses were $286000.0 (Q4 2025), $285000.0 (Q3 2025), and $276000.0 (Q2 2025) per Business Quant data.